Genetic Risk and LDL-C Response to Low-Carbohydrate and Low-Fat Diets: A Secondary Analysis of the DIETFITS Trial

Background: Variability in low-density lipoprotein (LDL-C) response to popular diets is well documented, but the factors contributing to this variability remain unclear. We examined whether genetic predisposition to high LDL-C impacts the effects of healthy low-carbohydrate (HLC) or healthy low-fat (HLF) diets on LDL-C. Methods: The Diet Intervention Examining the Factors Interacting with Treatment Success (DIETFITS) trial randomized 609 adults (ages 18-50 years; body mass index 28-40 kg/m2; not on lipid-lowering therapy) to a HLC or HLF diet for 12 months. This secondary analysis included 431 genotyped participants (HLC, n=223; HLF, n=208) with 24-hour recall and LDL-C data at baseline and 6 months. The primary exposure was a genome-wide polygenic score for LDL-C (PGS-LDL). The outcomes were 6-month change in LDL-C, LDL-C increase versus decrease, and new-onset hypercholesterolemia (LDL-C ≤ 130 mg/dL). Associations were evaluated using multivariable logistic and linear regression adjusted for baseline LDL-C, weight change, and other factors. Results: Mean baseline LDL-C was 116 mg/dL (SD, 26.1) in the HLC group and 111 mg/dL (SD, 30.6) in the HLF group. On average, LDL-C increased on the HLC diet (+4.7% [SD, 19]) and decreased on the HLF diet (-2.3% [SD, 22]), with substantial variability for both. In the HLC group, higher PGS-LDL was associated with risk for LDL-C increase (OR per 1-SD, 1.43; 95% CI, 1.02-2.05) and new hypercholesterolemia (OR per 1-SD, 2.27; 95% CI, 1.18-4.81). Similar effects on LDL-C lowering were not seen for HLF. In both, change in saturated fat intake was associated with change in LDL-C, independent of PGS-LDL, but this association was modified by PGS-LDL only in the HLC arm (P for interaction <0.0001). Conclusions: Risk for elevated LDL-C on a HLC diet is greater for individuals with genetic propensity to high LDL-C. This effect may be partly attributed to heightened sensitivity to saturated fat within a low-carbohydrate diet.

Authors

Institutions

Publication Details

Journal
medRxiv
Published
2026-11-18
DOI
https://doi.org/10.64898/2026.11.16.26367963
Primary Topic
Nutrition, Genetics, and Disease
Type
preprint

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
preprint

Genetic Risk and LDL-C Response to Low-Carbohydrate and Low-Fat Diets: A Secondary Analysis of the DIETFITS Trial

Alexa Barad, Christopher D. Gardner, Shoa L. Clarke
medRxiv
Nutrition, Genetics, and Disease
preprint

Genetic Risk and LDL-C Response to Low-Carbohydrate and Low-Fat Diets: A Secondary Analysis of the DIETFITS Trial

Alexa Barad, Christopher D. Gardner, Shoa L. Clarke
preprint en

Abstract

Background: Variability in low-density lipoprotein (LDL-C) response to popular diets is well documented, but the factors contributing to this variability remain unclear. We examined whether genetic predisposition to high LDL-C impacts the effects of healthy low-carbohydrate (HLC) or healthy low-fat (HLF) diets on LDL-C. Methods: The Diet Intervention Examining the Factors Interacting with Treatment Success (DIETFITS) trial randomized 609 adults (ages 18-50 years; body mass index 28-40 kg/m2; not on lipid-lowering therapy) to a HLC or HLF diet for 12 months. This secondary analysis included 431 genotyped participants (HLC, n=223; HLF, n=208) with 24-hour recall and LDL-C data at baseline and 6 months. The primary exposure was a genome-wide polygenic score for LDL-C (PGS-LDL). The outcomes were 6-month change in LDL-C, LDL-C increase versus decrease, and new-onset hypercholesterolemia (LDL-C ≤ 130 mg/dL). Associations were evaluated using multivariable logistic and linear regression adjusted for baseline LDL-C, weight change, and other factors. Results: Mean baseline LDL-C was 116 mg/dL (SD, 26.1) in the HLC group and 111 mg/dL (SD, 30.6) in the HLF group. On average, LDL-C increased on the HLC diet (+4.7% [SD, 19]) and decreased on the HLF diet (-2.3% [SD, 22]), with substantial variability for both. In the HLC group, higher PGS-LDL was associated with risk for LDL-C increase (OR per 1-SD, 1.43; 95% CI, 1.02-2.05) and new hypercholesterolemia (OR per 1-SD, 2.27; 95% CI, 1.18-4.81). Similar effects on LDL-C lowering were not seen for HLF. In both, change in saturated fat intake was associated with change in LDL-C, independent of PGS-LDL, but this association was modified by PGS-LDL only in the HLC arm (P for interaction <0.0001). Conclusions: Risk for elevated LDL-C on a HLC diet is greater for individuals with genetic propensity to high LDL-C. This effect may be partly attributed to heightened sensitivity to saturated fat within a low-carbohydrate diet.

medRxiv
Stanford Medicine (US), Stanford University (US)
National Heart, Lung, and Blood Institute, National Institute of Diabetes and Digestive and Kidney Diseases
Good health and well-being
Nutrition, Genetics, and Disease
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon